Navigation Links
Phase II trial of Bevacizumab (Avastin) in locally advanced cervical cancer 'promising'
Date:1/15/2014

An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer. The group reports that the addition of Bevacizumab to the existing standard of care was safe and showed promising overall results. The 2- and 3- year overall survival rates were 89.8 percent and 80.2 percent, respectively.

"Cervical cancer is a huge problem worldwide, but isn't as big a problem in the United States. So in many ways it tends to become a somewhat overlooked and under-studied disease," says Tracey Schefter, MD, investigator at the University of Colorado Cancer Center, director of the Stereotactic Body Radiation Therapy program at the University of Colorado School of Medicine, and the study's lead author.

Risk factors for cervical cancer include infection with the human papilloma virus (HPV). Screening dramatically reduces both the likelihood of developing cervical cancer and the disease's mortality rate. Combined, these two factors mean that 80 percent of the world's approximately 473,000 yearly cases of cervical cancer occur in the developing world. In the United States, cervical cancer rates have dropped 74 percent over the previous 50 years, but is still diagnosed in approximately 10,000 women per year, with 3,500 deaths due to the disease.

The current phase II clinical trial enrolled 49 eligible patients from 28 institutions in the years 2006-2009. The study previously reported that Bevacizumab was safe and well-tolerated in combination with cisplatin and radiation therapy in this population. Now the group reports on the secondary efficacy endpoints at a median follow-up time of 3.8 years.

Specifically the group evaluated the addition of 10mg/kg bevacizumab every two weeks for 3 cycles during
'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. ALS patients differ on treatment choices in later phases of disease
2. Reach2HD, a Phase II study in Huntingtons disease, launched
3. Analysis of KRYSTEXXA phase III data demonstrates improved health-related quality of life and physical function in refractory chronic gout patients
4. Phase III trial of dapivirine ring begins in Africa: New HIV prevention approach for women
5. IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
6. COPD Foundation and BWH announces second phase of groundbreaking COPDGene project
7. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
8. Positive results from Phase 1/2 stem cell trial reported
9. New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
10. Teva to present new Phase III data for QNASL® Nasal Aerosol at the 2012 ACAAI Meeting
11. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Phase II trial of Bevacizumab (Avastin) in locally advanced cervical cancer 'promising'
(Date:5/29/2015)... May 29, 2015 Mediaplanet has joined ... educate readers on the importance of proper sun protection. ... USA Today, with a circulation of approximately 250,000 copies ... component is distributed nationally, through a vast social media ... and partner outlets. To explore the digital version of ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Healthpointe ... consultations with specialists, physical therapy, and injections , ... mid back and/or lower back pain, Healthpointe has ... injections for herniated discs, disc protrusions and other ... , Healthpointe’s team of renowned surgeons are ...
(Date:5/29/2015)... The Croatia Cosmetic Dentistry Center - Clinica ... what modern dentistry options are available today. The partnered ... revolutionize the perception of a dental practice — combining ... , The top dental provider is partnered with ... agencies and led by world-renowned experts, Dr. Damir ...
(Date:5/29/2015)... Cokato, MN (PRWEB) May 29, 2015 ... Patio and Metro series outdoor saunas have increased ... backyard landscaping projects, and work at summer cottages. ... has piqued interest in summer projects a few weeks ... and suburban communities with smaller lot sizes tend to ...
(Date:5/29/2015)... Orion, Clarkston, Metamora, Michigan (PRWEB) May 29, 2015 ... the vulvar region and can cause significant physical, sexual, ... the major life altering disorder of Vulvodynia. The actual ... At Women’s Excellence in Endometriosis, they realize that this ... a patient is experiencing any of these symptoms, they ...
Breaking Medicine News(10 mins):Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3Health News:Croatian Cosmetic Dentistry Providers New Approach to Revolutionize Cosmetic Dentistry 2Health News:Croatian Cosmetic Dentistry Providers New Approach to Revolutionize Cosmetic Dentistry 3Health News:As Summer Approaches, Finnleo Notes Increased Interest in Patio and Metro Outdoor Saunas 2
... No. 1 in Health Care: Pharmacy and Other Services category; ... worldwideFRANKLIN LAKES, N.J., March 6 Medco Health Solutions, Inc. ... within the Health Care: Pharmacy and Other Services sector on ... addition, of all companies surveyed globally, Medco was ranked No. ...
... finds pulsed-dye beam with topical meds improved lesions in ... News) -- Laser therapy can safely and effectively treat ... small preliminary study of 18 people. , Fourteen of ... therapy (PDT) using a long-pulsed, pulsed-dye laser and a ...
... the course of a hospitalization, patients are seen ... the physician who has primary responsibility for their ... illegibility, lost paperwork or other problems may keep ... , An award-winning study by Martin Were, M.D., ...
... Are the First Ever Standardized Scales to Measure the ... Aesthetics, a division of Merz Pharmaceuticals USA, introduced The ... that measures, helps educate, and provides a common language ... process - at the American Academy of Dermatology,s (AAD) ...
... doctoral thesis presented at the Sahlgrenska Academy, University ... to describe and quantify the relationships between dose, ... and malaria. The method may allow improved treatment ... diseases. , Registered pharmacist Daniel Rshammar has in ...
... March 6 AMDL, Inc. (NYSE Alternext US: ... in China, announced today its Executive Chairman and ... at Security Research Associates, (SRA) 5th Annual Winter ... the 5th Annual Winter Technology Conference, Mr. MacLellan ...
Cached Medicine News:Health News:Medco Tops Fortune's Lists of 'World's Most Admired' Companies 2Health News:Medco Tops Fortune's Lists of 'World's Most Admired' Companies 3Health News:New Laser Combo Therapy Zaps Acne 2Health News:Giving doctors the complete picture 2Health News:Merz Aesthetics, a Division of Merz Pharmaceuticals USA, Introduces a Universal Language of Aging for Use in Education, Research and Practice 2Health News:Merz Aesthetics, a Division of Merz Pharmaceuticals USA, Introduces a Universal Language of Aging for Use in Education, Research and Practice 3Health News:Tools for more accurate dosage of drugs against HIV/AIDS and malaria 2Health News:AMDL, Inc. to Present at 5th Annual Winter Technology Conference Hosted by Security Research Associates, Inc. 2Health News:AMDL, Inc. to Present at 5th Annual Winter Technology Conference Hosted by Security Research Associates, Inc. 3
(Date:5/28/2015)... Calif. , May 28, 2015  IRIDEX Corporation (NASDAQ: ... Chief Financial Officer James H. Mackaness is scheduled ... 3, 2015, at 9:00 am PT in Los ... the presentation may be accessed on the Event Calendar of ...  A replay of the webcast will be available shortly after ...
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of the "United States ... report to their offering.      (Logo: ... adhesives in the United States ... 2020 Medical device manufacturers across ...
(Date:5/28/2015)... , May 28, 2015 The Parenteral ... be a supporting organization of the Johnson & ... in 2016. Johnson & Johnson (J&J) ... high-profile superbug infections in endoscopes. J&J ran 8 ... between 1976 and 2003 on advances in sterilization ...
Breaking Medicine Technology:United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3PDA Announces Support for the Johnson & Johnson Kilmer Conference 2
... 29, 2007 /PRNewswire-USNewswire/ -- Evidence is,accumulating that depression ... 2007 issue of Harvard Women's Health Watch. A,recent ... who regularly took,antidepressants called selective serotonin reuptake inhibitors,(SSRIs) ... not using such,medications. Other research points to depression ...
... CELSION CORPORATION,(AMEX:CLN) today announced the completion of ... to treat non-resectable liver,cancer. The study which ... Agreement (CRADA) was performed at the National,Cancer ... Health, under,the leadership of Dr. Steven K. ...
Cached Medicine Technology:Antidepressant Use May Boost Fracture Risk, From Harvard Women's,Health Watch 2Celsion Completes Enrollment in Phase I Liver Cancer Study 2Celsion Completes Enrollment in Phase I Liver Cancer Study 3
The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability....
... ADVIA 1650 has minimal requirements for sample ... consumption (as low as 80 L/test) and ... management efficiency. , , Outstanding productivity , ... of up to 1650 tests/hour provide powerful ...
... designed with a whole new level of ... to 2,000 tests per hour-a higher level ... higher level of efficiency and patient turn-around ... that allows for easy to use multi-view ...
... Standardized technology. Reagents, calibrators and controls ... minimize inventory, purchasing, and training costs. ... care system. Automated sample handling. 70 ... samples. 2-35 ml sample volumes. Intermix ...
Medicine Products: